4//SEC Filing
Backenroth Samuel 4
Accession 0001387131-17-005090
CIK 0001173281other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 6:02 PM ET
Size
5.5 KB
Accession
0001387131-17-005090
Insider Transaction Report
Form 4
Backenroth Samuel
CEO & VP of Bus. Development
Transactions
- Award
Stock Option (right to buy)
2017-10-16+350,000→ 350,000 totalExercise: $0.67Exp: 2022-10-15→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]1/3 of the shares of common stock subject to the stock option became exercisable immediately, and 1/3 of the shares of common stock subject to the stock option will become exercisable on each of October 16, 2018 and October 16, 2019.
Documents
Issuer
Ohr Pharmaceutical Inc
CIK 0001173281
Entity typeother
Related Parties
1- filerCIK 0001579887
Filing Metadata
- Form type
- 4
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 6:02 PM ET
- Size
- 5.5 KB